Annexin A3 (ANXA3), also known as lipocortin III and placental anticoagulant protein III, has
been reported to be dysregulated in tumor tissues and cancer cell lines, and harbors …

Kidney cancer [or renal cell carcinoma (RCC)] is known as “the internist's tumor” because it
has protean systemic manifestations, suggesting that it utilizes complex, nonphysiologic …

Annexin family proteins are a well-known multigene family of Ca 2+-regulated phospholipid-
and membrane-binding proteins. As one of the annexin family genes/proteins, accumulated …

Clear cell Renal Cell Carcinoma (ccRCC) is the most common and metastatic urological
cancer. Molecular players of ccRCC progression and metastasis are not completely known …

The adipocyte-like morphology of clear cell renal cell carcinoma (ccRCC) cells results from a
grade-dependent neutral lipid accumulation; however, the molecular mechanism and role in …

Clear cell renal cell carcinoma (ccRCC) has a poor prognosis despite novel biological
targeted therapies. Tumor aggressiveness and poor survival may correlate with tumor grade …

Early detection of resistance to platinum‐based therapy is critical for improving the treatment
of ovarian cancers. We have previously found that increased expression of annexin A3 is a …

Annexins are an extensive superfamily of structurally related calcium-and phospholipid-
binding proteins, largely conserved and widely distributed among species. Twelve human …

Annexin A3 (ANXA3) has been found to play important roles in cancer progression,
metastasis, and drug resistance; however, its role in hepatocellular carcinoma (HCC) …

Introduction As a member of annexin family proteins, annexin A3 (ANXA3) has 36-kDa and
33-kDa isoforms. ANXA3 plays crucial roles in the tumorigenesis, aggressiveness and drug …